Information

Illumina is renowned for its innovative technology and revolutionary assays that aim to analyze genetic variation and function. As an accelerator, Illumina provides entrepreneurs with access to cutting-edge genomic technology, comprehensive resources, and expert mentorship. Startups in the genomics and biotechnology sectors can benefit significantly from Illumina's vast network, funding opportunities, and technical support, which can accelerate their research and development processes, enhance product development, and increase market readiness. By partnering with Illumina, entrepreneurs gain a strategic advantage through collaboration with a leader in the genomics field.

How to Apply

To apply for Illumina's accelerator program, interested startups should prepare a detailed business plan that highlights their innovative approach to genomics or biotechnology. Applications can be submitted via Illumina's official website, where more specific guidelines and deadlines will be provided. It is advisable to include information about the team's expertise, the scientific basis of the technology, potential market impact, and any preliminary data or prototypes. Networking through industry events and reaching out via their LinkedIn page may also provide additional opportunities to connect with their team.

Total number of startups invested: 19

Average Funding: Details about the average funding round are not specified, but typically, Illumina invests in significant funding rounds to ensure comprehensive support for the development and scaling of genomic technologies.

Industry: Genomics, Biotechnology, Genetic Variation, Functional Analysis

Market: Illumina operates globally, with a strong presence in North America, Europe, and Asia.